Reviewed 3 Jun 2026

Completeness Fair (28%)

Aiosyn Mitosis: Mitotic figure counting

Aiosyn

No papers to support — we monitor for new evidence.

General Information

Product name

Aiosyn Mitosis: Mitotic figure counting

Company

Modality

Histopathology

Main task

Detection, Quantification

Subspeciality

Breast pathology

Organ/Specimen source

Not specified

Disease targeted

Breast cancer

Specimen type

Not specified

Staining

H&E

Stain subtype

Not specified

Regulatory Information

CE-IVD Certification

Pathway:

In Vitro Diagnostic Regulation (IVDR)

Class:

Class C

Not verified by Health AI Register

Scanner Brands Certified for Use (CE-IVD)

Not specified

Scanner Models Certified for Use (CE-IVD)

Not specified

Other certifications

Not specified

Evidence & Research

No research papers or evidence on file yet.

The registry monitors publications for new evidence.

Technical Specifications

Patient population age

Not specified

Input

Not specified

Input format

Not specified

Output

Not specified

Output format

Not specified

Integration

Not specified

Deployment

Not specified

Trigger for analysis

Not specified

Processing time

Not specified

Population

Not specified

Viewer systems

FullFocus (Paige), Telemis

Market Presence

On market since

May 2025

AI Platforms

Paige, Sectra Amplifier Store, Telemis

Resellers

Not specified

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Not specified

Based on

Not specified

First published: Jul 30, 2025 | Last updated: Jun 3, 2026